97-16067. Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 62, Number 118 (Thursday, June 19, 1997)]
    [Notices]
    [Page 33427]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-16067]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Nonprescription Drugs Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on July 14, 1997, 8:30 a.m. 
    to 5 p.m.
        Location: Holiday Inn, Versailles Ballrooms I and II, 8120 
    Wisconsin Ave., Bethesda, MD.
        Contact Person: Andrea G. Neal or Angie Whitacre, Center for Drug 
    Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-443-5455, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12541. Please call the Information Line for 
    up-to-date information on this meeting.
        Agenda: The committee will hear presentations and discuss the 
    proposed labeling requirements for over-the-counter (OTC) drug products 
    that will enable consumers to better read and understand OTC drug 
    product labeling and to apply this information to the safe and 
    effective use of OTC drug products. Elsewhere in this issue of the 
    Federal Register, FDA is also extending the comment period on a 
    proposed rule regarding labeling requirements for OTC drug products 
    that appeared in the Federal Register of February 27, 1997 (62 FR 
    9024).
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by July 3, 1997. 
    Oral presentations from the public will be scheduled between 
    approximately 1:15 p.m. to 2:15 p.m. Time allotted for each 
    presentation may be limited. Those desiring to make formal oral 
    presentations should notify the contact person before July 3, 1997, and 
    submit a brief statement of the general nature of the evidence or 
    arguments they wish to present, the names and addresses of proposed 
    participants, and an indication of the approximate time requested to 
    make their presentation.I11Notice of this meeting is given under the 
    Federal Advisory Committee Act (5 U.S.C. app. 2).
    
        Dated: June 12, 1997.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 97-16067 Filed 6-18-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/19/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-16067
Pages:
33427-33427 (1 pages)
PDF File:
97-16067.pdf